1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SMYD2 regulates chromatin modifier KMT2D in ER+/PIK3CA mutant breast cancer
    Meeting Abstract

    Blawski, R.; Sallaku, M.; Guo, X.; Kittane, S.; Scaltriti, M.; Luo, M.; Toska, E.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Self-assembling and disassembling (SADA) domain is critical to the binding, and anti-tumor efficacy of GD2-SADA
    Meeting Abstract

    Santich, B. H.; Kjellev, S. L.; Cheal, S.; Wang, L.; Gillberg, M.; Vadlamudi, M.; Ouattara, A. A.; Liebenberg, N.; Larsen, L. F.; Veach, D. R.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells
    Meeting Abstract

    Jain, N.; Zhao, Z.; Koche, R.; Gozlan, Y.; Brocks, D.; Raveh-Sadka, T.; Wells, D.; Dobrin, A.; Shi, Y.; Lopez, M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Migration of V600E-expressing cells is suppressed by ERK-dependent feedback inhibition of RAC1 and rescued in melanoma by secondary mutations
    Meeting Abstract

    Gadal, S.; Boyer, J. A.; Li, H.; Fan, N.; Chan, E.; Romin, Y.; De Stanchina, E.; Yeager, R.; Bosenberg, M.; Todorova, K. M.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Combining a novel MEK inhibitor with immunomodulation to promote an anti-tumor response
    Meeting Abstract

    Dong, L.; Choi, H.; Budhu, S.; Schulze, I.; Verma, S.; Mehanna, N.; Rosen, N.; Merghoub, T.; Wolchok, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MEKi-FGFRi combination nanoparticles for use against KRAS(mt)/FGFR-compensatory lung tumors
    Meeting Abstract

    Izawa-Ishiguro, A. R.; Sridharan, R.; Wun, C.; Sami, T. J.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Deferiprone alters macrophage function and metabolism
    Meeting Abstract

    Ackerstaff, E.; Budhu, S.; Winkleman, D. P.; Min, S. S.; Ijoma, J. N.; Serganova, I. S.; Blasberg, R. G.; Merghoub, T.; Koutcher, J. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • A human pluripotent stem cell derived differentiation model for the study of normal and transformed sympatho-adrenal progenitors
    Meeting Abstract

    Van Haver, S.; Fan, Y.; Van Loocke, W.; De Preter, K.; Kentsis, A.; Studer, L.; Roberts, S.; Speleman, F.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Acute kidney injury induced by allogeneic hematopoietic stem cell transplantation: disease understanding and treatment with nanotechnology-based therapeutics
    Meeting Abstract

    Panagiotakopoulou, M.; Grabarnik, E.; Jaimes, E. A.; van den Brink, M. R.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save